title: Deciding about prolonged ticagrelor therapy in coronary clot formers: an ongoing dilemma.
authors.affiliation: Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute, Fairfax, VA, USA pgurbel@lifebridgehealth.org paul.gurbel@inova.org.
authors.forename: Paul A
authors.initials: PA
authors.lastname: Gurbel
authors.affiliation: Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute, Fairfax, VA, USA.
authors.forename: Udaya S
authors.initials: US
authors.lastname: Tantry
mesh_terms: D054058:Acute Coronary Syndrome / Q000188:drug therapy*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D058921:Purinergic P2Y Receptor Antagonists / Q000627:therapeutic use; D013988:Ticlopidine / Q000627:therapeutic use*
chemical_list: D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D013988:Ticlopidine